14-day Premium Trial Subscription Try For FreeTry Free
$1.14
+0.0100 (+0.88%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.90 $2.14 Friday, 3rd May 2024 FGEN stock ended at $1.14. This is 0.88% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 9.43% from a day low at $1.12 to a day high of $1.22.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Nov 05, 2021 $12.74 $13.30 $12.74 $13.15 981 651
Nov 04, 2021 $12.73 $13.00 $12.60 $12.89 1 248 990
Nov 03, 2021 $12.10 $12.80 $12.03 $12.75 1 429 449
Nov 02, 2021 $11.65 $12.03 $11.49 $12.03 638 341
Nov 01, 2021 $11.13 $11.69 $11.06 $11.67 899 191
Oct 29, 2021 $11.11 $11.31 $10.97 $11.12 525 170
Oct 28, 2021 $10.71 $11.14 $10.51 $11.13 626 378
Oct 27, 2021 $10.91 $10.91 $10.59 $10.69 483 649
Oct 26, 2021 $11.25 $11.30 $10.83 $10.83 539 524
Oct 25, 2021 $10.86 $11.23 $10.77 $11.20 549 276
Oct 22, 2021 $10.52 $10.88 $10.29 $10.86 1 144 977
Oct 21, 2021 $10.34 $10.65 $10.34 $10.60 804 838
Oct 20, 2021 $10.71 $10.72 $10.30 $10.31 693 734
Oct 19, 2021 $10.79 $10.85 $10.64 $10.75 539 120
Oct 18, 2021 $10.86 $10.98 $10.52 $10.69 1 379 139
Oct 15, 2021 $11.63 $11.64 $10.98 $11.04 3 109 094
Oct 14, 2021 $11.15 $11.52 $11.05 $11.51 983 771
Oct 13, 2021 $10.68 $11.13 $10.63 $11.05 798 803
Oct 12, 2021 $10.46 $10.64 $10.34 $10.62 653 416
Oct 11, 2021 $10.50 $10.68 $10.39 $10.50 413 734
Oct 08, 2021 $10.33 $10.54 $10.31 $10.42 498 414
Oct 07, 2021 $10.31 $10.58 $10.25 $10.34 589 645
Oct 06, 2021 $10.20 $10.34 $10.15 $10.20 515 009
Oct 05, 2021 $9.93 $10.29 $9.93 $10.25 787 472
Oct 04, 2021 $10.25 $10.26 $9.88 $9.93 1 353 045
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT